Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.69 USD | +0.81% | +2.70% | -36.83% |
04-25 | Truist Securities Cuts Sage Therapeutics' Price Target to $18 From $22, Hold Rating Maintained | MT |
04-25 | Transcript : Sage Therapeutics, Inc., Q1 2024 Earnings Call, Apr 25, 2024 |
Sales 2024 * | 38.31M 52.36M | Sales 2025 * | 138M 189M | Capitalization | 824M 1.13B |
---|---|---|---|---|---|
Net income 2024 * | -399M -545M | Net income 2025 * | -325M -444M | EV / Sales 2024 * | 7.68 x |
Net cash position 2024 * | 530M 724M | Net cash position 2025 * | 337M 460M | EV / Sales 2025 * | 3.53 x |
P/E ratio 2024 * |
-2.06
x | P/E ratio 2025 * |
-2.72
x | Employees | 487 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.4% |
Latest transcript on Sage Therapeutics, Inc.
1 day | +0.81% | ||
1 week | +2.70% | ||
Current month | -26.95% | ||
1 month | -26.48% | ||
3 months | -48.07% | ||
6 months | -26.36% | ||
Current year | -36.83% |
Managers | Title | Age | Since |
---|---|---|---|
Barry Greene
CEO | Chief Executive Officer | 60 | 20-09-30 |
Steven Paul
FOU | Founder | 73 | 10-04-15 |
Kimi Iguchi
DFI | Director of Finance/CFO | 61 | 13-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeff Jonas
BRD | Director/Board Member | 71 | 13-08-13 |
Steven Paul
FOU | Founder | 73 | 10-04-15 |
Barry Greene
CEO | Chief Executive Officer | 60 | 20-09-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.13% | 16 M€ | -8.49% | ||
0.21% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 13.69 | +0.81% | 1,493,679 |
24-04-25 | 13.58 | -3.00% | 1,414,569 |
24-04-24 | 14 | +8.11% | 2,521,967 |
24-04-23 | 12.95 | +0.47% | 815,185 |
24-04-22 | 12.89 | -3.30% | 803,340 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-36.83% | 824M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- SAGE Stock